Guangdong, China

Qinying Zhu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Longuide Biopharma Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qinying Zhu. Retrieved from https://idiyas.com/inventor/qinying-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Qinying Zhu: Innovator in Lipid Nanoparticle Formulations**

Introduction

Qinying Zhu, based in Guangdong, China, is a distinguished inventor known for his contributions to the field of biopharmaceuticals. His innovative research primarily revolves around lipids and lipid nanoparticle formulations, paving the way for advanced methods of delivering nucleic acids, including mRNA, which is crucial in contemporary medical applications.

Latest Patents

Qinying Zhu holds a patent related to "Lipids and lipid nanoparticle formulations". This patent encompasses lipids and nanoparticle formulations designed for effective delivery of nucleic acids, which are essential in gene therapies and vaccines. His work is instrumental in developing systems that improve the efficiency and reliability of mRNA delivery.

Career Highlights

Currently, Qinying Zhu is affiliated with Longuide Biopharma Corporation, where he applies his expertise to develop innovative solutions in the pharmaceutical sector. His focus on lipid formulations showcases his commitment to advancing healthcare technologies and improving patient outcomes.

Collaborations

At Longuide Biopharma Corporation, Qinying collaborates with notable colleagues such as Longgui Zhang and Yuebao Zhang. Their joint efforts exemplify a collaborative spirit in research and innovation, fostering breakthroughs in lipids and delivery systems.

Conclusion

Qinying Zhu represents a significant figure in the realm of biopharmaceutical innovations, with his patent contributing to the evolving landscape of mRNA technology. His work at Longuide Biopharma Corporation, paired with strategic collaborations, positions him as a key player in the future of medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…